These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

893 related articles for article (PubMed ID: 9520021)

  • 1. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications.
    Chlebus E; Wolska H; Blaszczyk M; Jablonska S
    J Am Acad Dermatol; 1998 Mar; 38(3):405-12. PubMed ID: 9520021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).
    Tiao J; Feng R; Carr K; Okawa J; Werth VP
    J Am Acad Dermatol; 2016 May; 74(5):862-9. PubMed ID: 26897388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus: clinical expression and anti-Ro/SS--a response in patients with and without lesions of subacute cutaneous lupus erythematosus.
    López-Longo FJ; Monteagudo I; González CM; Grau R; Carreño L
    Lupus; 1997; 6(1):32-9. PubMed ID: 9116716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients.
    Tebbe B; Mansmann U; Wollina U; Auer-Grumbach P; Licht-Mbalyohere A; Arensmeier M; Orfanos CE
    Acta Derm Venereol; 1997 Jul; 77(4):305-8. PubMed ID: 9228225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on criteria of the European Academy of Dermatology and Venerology for the classification of cutaneous lupus erythematosus. I. Selection of clinical groups and study factors.
    Beutner EH; Blaszczyk M; Jablonska S; Chorzelski TP; Kumar V; Wolska H
    Int J Dermatol; 1991 Jun; 30(6):411-7. PubMed ID: 1894405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus.
    Black DR; Hornung CA; Schneider PD; Callen JP
    Arch Dermatol; 2002 Sep; 138(9):1175-8. PubMed ID: 12224978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
    Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
    Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced lupus erythematosus.
    Marzano AV; Tavecchio S; Menicanti C; Crosti C
    G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.
    David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA
    J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients.
    Vera-Recabarren MA; García-Carrasco M; Ramos-Casals M; Herrero C
    Br J Dermatol; 2010 Jan; 162(1):91-101. PubMed ID: 19785596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cutaneous pathology associated with seropositivity for antibodies to SSA (Ro): a clinicopathologic study of 23 adult patients without subacute cutaneous lupus erythematosus.
    Magro CM; Crowson AN
    Am J Dermatopathol; 1999 Apr; 21(2):129-37. PubMed ID: 10218672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus.
    Cohen MR; Crosby D
    J Rheumatol; 1994 Sep; 21(9):1665-9. PubMed ID: 7799346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Ro/SS-A antibodies in lupus erythematosus: what does it mean for the dermatologist?
    Böckle BC; Stanarevic G; Sepp NT
    J Am Acad Dermatol; 2013 Mar; 68(3):385-94. PubMed ID: 23069705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARA and EADV criteria for classification of systemic lupus erythematosus in patients with cutaneous lupus erythematosus.
    Parodi A; Rebora A
    Dermatology; 1997; 194(3):217-20. PubMed ID: 9187836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subacute cutaneous lupus erythematosus: clinical aspects, immunology and therapy].
    Ruzicka T; Bieber T; Meurer M
    Wien Klin Wochenschr; 1987 Dec; 99(23):802-7. PubMed ID: 3324494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lupus erythematosus].
    Goerz G; Lehmann P; Schuppe HC; Lakomek HJ; Kind P
    Z Hautkr; 1990 Mar; 65(3):226, 229-34. PubMed ID: 2339576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
    Walling HW; Sontheimer RD
    Am J Clin Dermatol; 2009; 10(6):365-81. PubMed ID: 19824738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17 in cutaneous lupus erythematosus.
    Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
    Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subacute cutaneous lupus erythematosus.
    David-Bajar KM
    J Invest Dermatol; 1993 Jan; 100(1):2S-8S. PubMed ID: 8423385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.